{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:22:03Z","timestamp":1784953323708,"version":"3.55.0"},"reference-count":20,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T00:00:00Z","timestamp":1638057600000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"KCE","award":["KCE19-1224"],"award-info":[{"award-number":["KCE19-1224"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,10,28]]},"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Tubal patency testing is an essential part in the fertility workup of many subfertile women. Hysterosalpingography (HSG) has long been the test of choice in many clinics. There is evidence from a large randomised multicentre trial and from a recent meta-analysis that women who had HSG using oil soluble contrast medium (OSCM) had higher rates of ongoing pregnancy compared with women who underwent this procedure using water contrast. However, the field is moving away from HSG and nowadays hysterosalpingo-foam sonography (Hyfosy) using ultrasound guidance is considered as the first line office tubal patency test. Therefore, a large multicentre randomised clinical trial (RCT) will be initiated to evaluate if flushing the fallopian tubes with OSCM after a normal Hyfosy showing at least one patent fallopian tube will increase the live birth rate as compared with no flushing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We plan a multicentre two arm, 1:1 randomised, open-label pragmatic comparative trial in 12 Belgian centres. After informed consent, we will randomise infertile women between 18 and 40 years of age, undergoing Hyfosy as part of the fertility workup to Hyfosy with additional tubal flushing with OSCM versus Hyfosy without additional flushing. Infertility is defined as lack of conception despite 12 months of unprotected intercourse, or three cycles of donor insemination without pregnancy or three ovulatory ovulation induction cycles without pregnancy, all three in combination with at least one patent tube on Hyfosy. Primary endpoint will be live birth with conception within 6 months after randomisation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Approval on 11 May 2021 by the Ethics Committee from ZNA Hospital Antwerp who was the central Ethics Committee for the Clinical Trial Regulation Pilot (Pilot 412) in the 12 centres. The findings from this RCT will be disseminated in peer-reviewed publications and presentations at scientific international meetings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration numbers<\/jats:title>\n                    <jats:p>\n                      EudraCT number: 2020-002135-30 and\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04379973\">NCT04379973<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-054845","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T11:11:58Z","timestamp":1638184318000},"page":"e054845","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Live birth after additional tubal flushing with oil-based contrast versus no additional flushing: a randomised, multicentre, parallel-group pragmatic trial in infertile women with at least one patent tube at hysterosalpingo-foam sonography (HYFOIL study)"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct04379973","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9159-5083","authenticated-orcid":false,"given":"Diane","family":"De Neubourg","sequence":"first","affiliation":[{"name":"Centre for Reproductive Medicine, Antwerp University Hospital, Edegem, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Janssens","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, Antwerp University Hospital, Edegem, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Verhaegen","sequence":"additional","affiliation":[{"name":"Clinical Trial Centre, Antwerp University Hospital, Edegem, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Smits","sequence":"additional","affiliation":[{"name":"Clinical Trial Centre, Antwerp University Hospital, Edegem, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8337-550X","authenticated-orcid":false,"given":"Ben W","family":"Mol","sequence":"additional","affiliation":[{"name":"OB\/GYN, School of Medicine, Monash University, Clayton VIC, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Roelant","sequence":"additional","affiliation":[{"name":"Clinical Trial Centre, Antwerp University Hospital, Edegem, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,11,29]]},"reference":[{"key":"2025121410380762000_11.11.e054845.1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(02)09417-5","article-title":"Female subfertility","volume":"360","author":"Evers","year":"2002","journal-title":"The Lancet"},{"key":"2025121410380762000_11.11.e054845.2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0015-0282(16)30725-7","article-title":"Therapeutic value of salpingograms in infertility","volume":"2","author":"Weir","year":"1951","journal-title":"Fertil Steril"},{"key":"2025121410380762000_11.11.e054845.3","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-38-448-301"},{"key":"2025121410380762000_11.11.e054845.4","first-page":"CD003718","article-title":"Tubal flushing for subfertility","volume":"5","author":"Mohiyiddeen","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121410380762000_11.11.e054845.5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/uog.20238","article-title":"Effectiveness on fertility outcome of tubal flushing with different contrast media: systematic review and network meta-analysis","volume":"54","author":"Wang","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2025121410380762000_11.11.e054845.6","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMoa1612337","article-title":"Oil-Based or water-based contrast for hysterosalpingography in infertile women","volume":"376","author":"Dreyer","year":"2017","journal-title":"N Engl J Med"},{"key":"2025121410380762000_11.11.e054845.7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.fertnstert.2018.03.021","article-title":"Oil-Based versus water-based contrast for hysterosalpingography in infertile women: a systematic review and meta-analysis of randomized controlled trials","volume":"110","author":"Fang","year":"2018","journal-title":"Fertil Steril"},{"key":"2025121410380762000_11.11.e054845.8","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/13.11.3049"},{"key":"2025121410380762000_11.11.e054845.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0720-048X(99)00127-8"},{"key":"2025121410380762000_11.11.e054845.10","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.fertnstert.2014.05.042","article-title":"Hysterosalpingo-foam sonography, a\u00a0less painful procedure for tubal patency testing during fertility workup compared with (serial) hysterosalpingography: a randomized controlled trial","volume":"102","author":"Dreyer","year":"2014","journal-title":"Fertil Steril"},{"key":"2025121410380762000_11.11.e054845.11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/uog.14646","article-title":"Pain during Fallopian-tube patency testing by hysterosalpingo-foam sonography","volume":"45","author":"Van Schoubroeck","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2025121410380762000_11.11.e054845.12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/uog.15100","article-title":"OC24.01: spontaneous conception after hysterosalpingo-foam sonography (HyFoSy)","volume":"46","author":"Van Schoubroeck","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2025121410380762000_11.11.e054845.13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/ajo.12716","article-title":"Hysterosalpingo-foam sonography (HyFoSy): tolerability, safety and the occurrence of pregnancy post-procedure","volume":"58","author":"Tanaka","year":"2018","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2025121410380762000_11.11.e054845.14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmig.2015.08.836","article-title":"Can tubal flushing with Hysterosalpingo-Foam sonography (HyFoSy) media increase women\"s chances of pregnancy?","volume":"22","author":"Exacoustos","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"2025121410380762000_11.11.e054845.15","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1080\/09513590.2017.1307960","article-title":"The effect of oil and water-soluble contrast medium in hysterosalpingography on thyroid function","volume":"33","author":"So","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"2025121410380762000_11.11.e054845.16","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1210\/jc.2014-2731","article-title":"Changes in serum iodine concentration, urinary iodine excretion and thyroid function after hysterosalpingography using an oil-soluble iodinated contrast medium (lipiodol)","volume":"100","author":"Kaneshige","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2025121410380762000_11.11.e054845.17","doi-asserted-by":"publisher","DOI":"10.1159\/000439381"},{"key":"2025121410380762000_11.11.e054845.18","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/humrep\/deaa049","article-title":"Thyroid function in neonates conceived after hysterosalpingography with iodinated contrast","volume":"35","author":"van Welie","year":"2020","journal-title":"Hum Reprod"},{"key":"2025121410380762000_11.11.e054845.19","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der171"},{"key":"2025121410380762000_11.11.e054845.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.02.046"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-054845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T18:38:16Z","timestamp":1765737496000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-054845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,29]]},"published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10.1136\/bmjopen-2021-054845"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-054845","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}